Dr. Milowsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-0000Fax+1 919-843-6949
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1999 - 2002
- Tufts Medical CenterResidency, Internal Medicine, 1996 - 1999
- State University of New York Downstate Medical Center College of MedicineClass of 1996
Certifications & Licensure
- NC State Medical License 2011 - 2025
- NY State Medical License 1999 - 2013
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma Start of enrollment: 2008 Jul 01
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer Start of enrollment: 2012 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 59 citationsPhase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder CancerTracy L. Rose, Michael R. Harrison, Allison M. Deal, Sundhar Ramalingam, Young E. Whang
Journal of Clinical Oncology. 2021-08-24 - 168 citationsGuideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideli...Matthew I. Milowsky, R. Bryan Rumble, Christopher M. Booth, Timothy D. Gilligan, Libni J. Eapen
Journal of Clinical Oncology. 2016-09-27 - 90 citationsMulticenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder CancerGopa Iyer, Arjun Vasant Balar, Matthew I. Milowsky, Bernard H. Bochner, Guido Dalbagni
Journal of Clinical Oncology. 2018-05-09
Press Mentions
- Bladder Cancer Biomarkers Promise Improved SurvivalNovember 14th, 2024
- Treatment Advances, Predictive Biomarkers Stand to Improve Bladder Cancer CareNovember 13th, 2024
- Carolina Cancer Experts Available for InterviewsMay 19th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: